Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021

Report Summary :

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, rising healthcare expenditure, and increased access to medical insurance in developed countries are driving growth in the caner immunotherapy market.  

The global cancer immunotherapy market has been segmented on the basis of type, application, end user, and region. The monoclonal antibodies segment is expected to register the highest growth rate in the cancer immunotherapy market, by type, during the forecast period. Factors such as high success rate and less recovery time are contributing to the high growth in this segment.

Table of Contents


1 INTRODUCTION 13

2 RESEARCH METHODOLOGY 16

3 EXECUTIVE SUMMARY 24

4 PREMIUM INSIGHTS 29

5 MARKET OVERVIEW 32

6 INDUSTRY TRENDS 39

7 CANCER IMMUNOTHERAPY MARKET, BY PRODUCT TYPE 49

8 CANCER IMMUNOTHERAPY MARKET, BY APPLICATION 68

9 CANCER IMMUNOTHERAPY MARKET, BY END USER 80

10 CANCER IMMUNOTHERAPY MARKET, BY REGION 85

11 COMPETITIVE LANDSCAPE 97

12 COMPANY PROFILE 106

For More Details VISIT @ http://www.grandresearchstore.com/medical-devices/cancer-immunotherapy-market-by-type-monoclonal-antibodies-cancer-vaccines-check-point-inhibitors-26-immunomodulators-application-lung-breast-colorectal-melanoma-prostate-head-26-neck-end-user-hospital-and-clinics---global-forecast-to-2021